Skip to main content
. 2018 Jan 16;27(1):4–14. doi: 10.1007/s40629-017-0046-7

Table 3.

Patients receiving diagnostic workup and information regarding venom immunotherapy (VIT) by follow-up provider classification

Follow-up provider No. Received diagnostic workup (%) Received VIT information (%)
Tertiary (allergist) 38 100 97
Secondary (allergist) 12 92 92
Primary (allergist) 18 100 83
Non-allergist provider 35 51 34